MSD TENDER NUMBERS CLOSING ON 09/10/2020 at 10.00 Am: Tender No Item Quantit Y Pack Size Delivery

MSD TENDER NUMBERS CLOSING ON 09/10/2020 at 10.
00 am
TENDER NO ITEM QUANTIT PACK DELIVERY
Y SIZE
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00426 30 01 TAB IMMEDIATELY with
DHS/NRQ/356/ SR No 00109802 TABS 15 months Residual
(E)/2020 Shelf Life
Item Ribavirin tablet 200mg
Specification Ribavirin Tablet 200mg

Value of Bid Bond 39.71
(LKR)
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00437 44 01 VIAL IMMEDIATELY with
DHS/RQ/355/ SR No 00603102 VIALS 15 months Residual
(E)/2020 Shelf Life
Item Antithymocyte inj. 250mg,5mlvial
Specification Antithymocyte Globulin (equine)for IV use, 250mg in 5ml vial
Value of Bid Bond 36,587.50
(LKR)
DHS/NRQ/354/ SR No 00802901 VIALS 15 months Residual
(E)/2020 Shelf Life
Item C1 Esterase inhibitor (Recombinant) powder for solution vial
2100 U
Specification C1 Esterase inhibitor (Recombinant) powder for solution vial

2100U
(LKR)
Y SIZE
DHS/RQ/353/ SR No 00307602 TABS 15 months Residual
(E)/2020 Shelf Life
Item Enzyme Co Q10 tablet 100mg
Specification Enzyme Co Q10 tablet 100mg
(LKR)
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00417 180 01 CAP IMMEDIATELY with
DHS/NRQ/352/ SR No 00307701 caps 15 months Residual
(T)/2020 Shelf Life
Item Stiripentol capsule 500mg
Specification Stiripentol capsule 500mg

(LKR)
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00424 36 01 CAP IMMEDIATELY with
DHS/NRQ/351/ SR No 00307601 caps 15 months Residual
(E)/2020 Shelf Life
Item Enzyme Co Q10 capsule 100mg
Specification Enzyme Co Q10 capsule 100mg

(LKR)
(E)/2020 Shelf Life
(LKR)
Y SIZE
(E)/2020 Shelf Life
(LKR)
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00412 1 01 BOT IMMEDIATELY with
DHS/RQ/348/ SR No 00305903 bot 15 months Residual
(E)/2020 Shelf Life
Item Levetiracetam Oral Solution 100mg /ml in 300ml Bottle
Specification Levetiracetam Oral Solution 100mg /ml in 300ml Bottle each

bottle to contain 100mg /ml Levetiracetam BP/USP
Note:
01.The shelf life of the product should be minimum of 24 months
(LKR)
(E)/2020 Shelf Life
Item Inosine pranobex tablet 500mg
Specification Inosine pranobex tablet 500mg
(LKR)
TENDER NO ITEM QUANTITY PACK DELIVERY
SIZE
LP/MSD/CPU- MSD O/L No 2020/SPC/L/R/P/00387 1,108,914 50'S IN A IMMEDIATELY with
DHS/RQ/346/ SR No 00101406 Vials BOX 12 months Residual
(T)/2020 Shelf Life
Item Cefuroxime Injection 750mg Vial
Specification Cefuroxime Sodium for Injection BP, 750mg

OR
Cefuroxime for Injection USP, 750mg
Each vial shall contain sterile Cefuroxime Sodium BP/USP
equivalent to 750mg of
Crystalline Cefuroxime as sterile dry powder for reconstitution
with sterile Water for
injection ,for intramuscular or intravenous injection or
intravenous infusion. 750mg vial should contain no more than
1.8mmol of sodium.
1.This injection should be stable for a minimum of 24

months when stored at a temperature not exceeding
25'C.
2.It should be protected from light.
(LKR)
SIZE
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00622 156 156 IMMEDIATELY with
DHS/RQ/345/ SR No 01207701 VIALS VIALS 15 months Residual
(T)/2020 Shelf Life
Item Tocilizumab 80mg/4ml for IVinfusion
Specification Tocilizumab 80mg/4ml, concentrate solution for infusion
Each 1 ml of concentrate to contain 20 mg of tocilizumab
solution for infusion
Note:
1. This injection should be stable for a minimum 24 months
when stored at a temperature range of 2'C - 8'C
2. Each vial should be labeled accordingly

(LKR)
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00634 90 90 TABS IMMEDIATELY with
(E)/2020 Shelf Life
Item Tenofovir alafenamide Tablet 25mg
Specification tenofovir alafenamide Tablet 25mg

(LKR)
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00719 1,169 1169 PFS IMMEDIATELY with
DHS/RQ/384/ SR No 01205904 PFS 15 months Residual
(E)/2020 Shelf Life
Item Interferone beta 1a injection30 mcg PFS
Specification Interferone beta 1a injection 30mcg PFS
Each 0.5 ml pre-filled syringe to contains 30 mcg of interferon-
beta-1a
(LKR)
SIZE
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00718 1,716 1716 PFS IMMEDIATELY with
DHS/RQ/359/ SR No 01205902 PFS 15 months Residual
(E)/2020 Shelf Life
Item Interferon beta 1-a injection 44mcg prefilled syringe
Specification Interferon beta 1-a 44mcg Injection, 12000000 IU in 0.5ml, in

prefilled syringe
Note:
(LKR)
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00635 730 730 TABS BY 31/10/2020 with
(E)/2020 Shelf Life
Item Tenofovir tab. 300mg
Specification Tenofovir Disoproxil Fumarate Tablets 300mg

(LKR)
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00773 60,000 120'S IN 40,000 TABS -
DHS/RQ/376/ SR No 01208501 TABS A PACK 30/10/2020
(E)/2020 20,000 TABS -
Item Abiraterone acetate tablet 250mg
30/11/2020 with 15
months Residual
Specification Abiraterone acetate tablet 250mg Shelf Life
Each tablet to contain 250mg of Abiraterone acetate
Note:
(LKR)
SIZE
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00769 272 01 PFS 150 PFS BY
DHS/NRQ/370/ SR No 01401802 PFS 30/10/2020
(E)/2020 122 PFS BY
Item Denosumab inj. 60mg in 1ml
Specification Denosumab injection 60mg in 1ml 30/11/2020 with 15
months Residual
Shelf Life
(LKR)
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00445 9 01 BY 09/11/2020 with
DHS/RQ/381/ SR No 00900802 IMPLANTS IMPLANT 15 months Residual
(T)/2020 Shelf Life
Item Dexamethasone Intravitreal Implant 0.7mg
Specification Dexamethasone Intravitreal Implant 0.7mg

(LKR)
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00730 226 226 BY 30/10/2020 with
DHS/RQ/368/ SR No 00603102 VIALS VIALS 15 months Residual
(T)/2020 Shelf Life
(LKR)
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00779 168 01 VIAL BY 20/10/2020 with
DHS/NRQ/379/ SR No 01212301 VIALS 15 months Residual
(E)/2020 Shelf Life
Item Carfilzomib Injection 30mg vial
Specification Carfilzomib Injection 30mg vial
(LKR)
SIZE
(T)/2020 Shelf Life
Item Ruxolitinib tablet 15mg
Specification Ruxolitinib tablet 15mg

Each tablet to contain 15mg of Ruxolitinib phosphate.
Note:
01.The shelf life of the product should be minimum of 24
months.
(LKR)
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00735 2,520 2,520 BY 30/10/2020 with
DHS/RQ/366/ SR No 01209302 TABS TABS 15 months Residual
(T)/2020 Shelf Life

Note:
months.
(LKR)
SIZE
(T)/2020 Shelf Life

Note:
months.
(LKR)
(T)/2020 Shelf Life

Note:
months.
(LKR)
SIZE
(T)/2020 Shelf Life

Note:
months.
(LKR)
(T)/2020 Shelf Life

Note:
months.
(LKR)
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00640 730 730 CAPS BY 31/10/2020 with
DHS/NRQ/361/ SR No 00308501 CAPS 15 months Residual
(T)/2020 Shelf Life
Item Miglustat Capsules 100mg
Specification Miglustat Capsules 100mg
(LKR)
SIZE
LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00727 39 39 IMPL IMMEDIATELY with
DHS/RQ/357/ SR No 00900802 IMPL 15 months Residual
(T)/2020 Shelf Life
Item Dexamethasone Intravitreal Implant 0.7mg
Specification Dexamethasone Intravitreal Implant 0.7mg

(LKR)
conditions to the Tender
You are requested to indicate the lowest price in Sri Lankan Rupees that could be afforded.
A Certified copy of the National Medicines Regulation Authority (NMRA – Sri Lanka) Registration Certificate, Certificate of Analysis (COA) should
be forwarded along with the quotation.
In addition, the following information also should be indicated in your quotation.
1. Delivery Date
2. Availability of Ex-Stocks (Ex- Stocks are expected to be supplied within two (02) working days after placing the order.
3. Delivery Schedule / date (in case if Ex- Stocks are not available)
4. Shelf Life of the item (Date of Manufacture and Date of Expiry)
5. Related Tender Number, SR number of the item and description of item.
6. Contact details of the bidder (Contact Person, TP Nos, (Land/mobile), Fax, e-mail)
Your quotation / quotations shall be placed in the relevant tender box; which is placed in the Internal Audit Department of the Head Office of the State
Pharmaceuticals Corporation. prior to closing date and time indicated above. (Any late delivered / submitted bids will be rejected without accepting)
Tender Samples, with clear indication of the Tender No, shall be handed over to the Administration Department on or before the closing of tender and
acknowledgement of such samples should be attached to the quotation (bid).
SPC reserves the right to call samples from bidders who have not submitted samples before closing of the tender in cases of none of the bidders had
submitted samples, evaluators are with the opinion of calling samples from bidders who have not submitted samples and / or the Procurement committee
is with the opinion of calling of samples from the bidders who have not submitted samples will help them to make a cost effective decision.
Note
1. Please indicate the current market whole sale and Retail prices in your quotation (bid)
2. Your Quotation (bid) shall be submitted in one original and one duplicate, sealed separately and marked as “ORIGINAL” and “DUPLICATE”
respectively. Both envelopes shall be enclosed in one envelop and deposited in the tender box kept in the Internal Audit Department.
3. In case if the supplier / manufacturer is not registered with NMRA – Sri Lanka, please provide following details together with the bid
(Quotation)
i) GMP certificate
ii) Certificate of Pharmaceutical Products
iii) Manufacturer’s information letter
iv) Certificate of Analysis of the Product
Bid Evaluation Summary Sheet

Format of the “Bid Evaluation Summary Sheet” is published in SPC website [www.spc.lk]
All potential bidders should submit duly filled “Bid Evaluation Summary Sheets” together with the bid.
Soft copy (Only in MS Excel Format) should be e-mailed to techtender@spc.lk within 02 working days of Tender closing.
Non-Submission of Bid Evaluation Summary Sheets will be treated as Non-Compliance of conditions of bidding and such bids
will be treated as Non-Responsive at the time of tender evaluations.
Bidders should furnish an unconditional Bid Bond encashable on first written demand to the value stated against each item of the
Bidding Document.
Bid Bond should be submitted together with the Bid or to reach SPC on or before the closing date and time of Bid.
Bids submitted without Bid Bonds, will not be considered.
The Bid Bond should be valid for at least 60 days beyond the validity of the Bid. (The amount of bid bond is indicated against
each item of the Bidding Document)
The Bid Bond shall be as per specimen at Annex I and shall be issued by one of the following institutions.
i. A Commercial Bank operating in Sri Lanka, approved by the Central Bank of Sri Lanka.
ii. ii. A Bank based in another country but the security or guarantee “Confirmed” by a Commercial Bank operating in
Sri Lanka.
iii. iii. A Letter of Credit issued by a Foreign Bank, but ‘Confirmed’ by a Commercial Bank operating in Sri Lanka.
iv. iv. Any other Agency approved by the Treasury from time to time.
Or
v. A cash deposit
Bids which do not comply with this requirement will be rejected. If Procurement Committee makes a request to extend the validity
of the Bid Bond, the bidder may have to honour that request.
CONDITIONS OF SUPPLY
1. The Product should have minimum of 15 months / 12 months shelf life at the time of delivery at Medical Supplies Division (As indicated under “Delivery” of
each item in the above schedule)
2. Description of item, Date of manufacture, Date of expiry, Batch No, Name and address of manufacture Should be clearly marked on the outer covering
containing the item and on the outer cover of the carton/box.
3. Offers for any other economically viable pack sizes different from the specify pack sizes are acceptable with the prior approval of Director Medical Supplies
Division.
4. MSD Order List No, SR No. of Item, SPC Indent No/purchase order no Description and storage condition of item and Batch No shall be indicated in all Supply
Invoices.
5. Storage condition of the items should be clearly indicated in the inner most and outer most carton labels.
6. Cold chain monitors should be included for each cartons and the cold chain should be maintained according to the manufacturer's instructions during
storage, transport and delivery.
7. Delivery of the items is to be made to free of charge.
8. Withdrawal from use of Item due to quality failure.

a) In case of batch withdrawal due to quality failure, the supplier/ manufacturer shall reimburse the value of entire batch quantity supplied.
b) In case of product withdrawal due to quality failure, the supplier/ manufacturer shall reimburse the value of entire product quantity supplied.
c) In the event of either a) or b) above the supplier/manufacturer shall be surcharged additional 25% of the total value concerned as administrative
cost.
9. Standard- any other pharmaceutical standard accepted by cosmetics, devices and drugs regulatory authority in Sri-Lanka for registration of pharmaceutical
item also acceptable.
10. In the event that item is awarded to unregistered bidder, the NOL/PUL issued by NMRA should be submitted when item is delivered. If not, payment will
not be released for the delivered item. (In case of applying for NOL, relevant fee due to NMRA shall be borne by the supplier)
11. In the event of failing to supply the item within the delivery schedule given the Purchase order the item will not be accepted by MSD. However, if the item
is still required by Medical Supplies Division and decides to accept the same , a penalty of 0.1% of the total value per day up to 7 days(total of 0.7% for 1st
7days of late delivery), 0.3%per total value per day from 8th to 14th (another 2.1% for 7 days from 8th to 14th day of late delivery),0.5% per total value per
day from 15th to 21st day (another 3.5% for the period from 15th to 21st day of late delivery) for the lapsed period will be deducted from your payment as
liquidated damage.
In case of an item delivered after 3 weeks, if the item is still required MSD reserves the right to accept maximum penalty of 10% of the total value will be
imposed.
12. In addition to the condition given herein any other relevant condition as per the tender document issued by SPC are also applicable.
13. IN CASE OF AWARD, DELIVERY OF SPC MAIN ORDER(S) WILL BE CONSIDERED PRIOR TO RELEASEING THE INDENT / PURCHASE ORDER FOR THE LOCAL
SUPPLY
Annex 1
SPECIMEN FORM OF BID SECURITY (BID BOND)
By this Bond We ………………………………………………………………………………………… (hereinafter called “the Bidder”) and We (name of bank or insurance company) whose registered office is at
………………………………………………………………..(hereinafter called “the Surety”) are held and firmly bound unto ………………………………………………………… ……………………………………………………………………………..
(hereinafter called “the Authority”) in the sum of for the payment of which sum the Bidder and the Surety bind themselves their successors and assigns jointly and severally by these presents.
Whereas the Authority has invited the Bidder and other persons to complete bids in similar terms for the supply of …………………………………………………………………………… to submit the same for the
consideration of the Authority, and the Bidder proposes to submit to the Authority a bid (hereinafter called “the Bid”) in accordance with such invitation, the Bond shall provide security to the
Authority that the Bidder will honour certain obligations to be undertaken by him in the Bid in accordance with the following conditions.
Now the Conditions of this Bond are:
(a) that it shall remain in full force and effect until the earliest of
(i) (date), being ( ) days from (submission date), the date stipulated by the Authority for the submission of bids, or any prolongation of such date above notified to the Authority by the Bidder
and the Surety in writing;
(ii) in the event of acceptance of the Bid by the Authority, the date upon which the Bidder provides a performance security to the Authority in accordance with the terms of the contract
thereby made between them, or
(iii) in the event of acceptance by the Authority of a bid for the Works from a third party, the date upon which such third party provides the relevant performance security.
(b) subject to this Bond being in full force and effect, the Surety shall pay the full amount specified in this Bond upon receipt of first written demand from the Authority stating that
(i) the Bidder has withdrawn his Bid during the validity of this Bond, or
(ii) the Bidder has failed to provide a performance security to the Authority in accordance with the terms of the contract between them upon acceptance of the Bid.
No alteration in the terms of the Bid, nor any forbearance or forgiveness in or in respect of any matter or thing concerning the Bid on the part of the Authority, nor any objection from the bidder shall
in any way release the surety from any liability under this Bond.
The benefit of this Bond shall not be assignable by the Authority and upon its ceasing to be in full force and effect the Authority shall return the same to the Bidder.
This Bond shall be governed by the laws of ( )
I executed as a Deed this( )day of ( )20( )
For and on behalf of the Bidder ……………… … For and on behalf of the Surety…………….
……………………………………………………… …………………………………………………
Signed by ………………………………………… Signed by ……………………………………
In the capacity of ……………………………….. and by ……………………………………….
in the capacity of ……………………………. In the capacity of ……………………………
Seal (where applicable). Seal (where applicable)

MSD TENDER NUMBERS CLOSING ON 09/10/2020 at 10.00 Am: Tender No Item Quantit Y Pack Size Delivery

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

MSD TENDER NUMBERS CLOSING ON 09/10/2020 at 10.00 Am: Tender No Item Quantit Y Pack Size Delivery

Uploaded by

Copyright:

Available Formats

MSD TENDER NUMBERS CLOSING ON 09/10/2020 at 10.

Specification Ribavirin Tablet 200mg

Specification C1 Esterase inhibitor (Recombinant) powder for solution vial

Specification Stiripentol capsule 500mg

Specification Enzyme Co Q10 capsule 100mg

Specification Levetiracetam Oral Solution 100mg /ml in 300ml Bottle each

Specification Cefuroxime Sodium for Injection BP, 750mg

1.This injection should be stable for a minimum of 24

Value of Bid Bond 58,997.70

Specification tenofovir alafenamide Tablet 25mg

Specification Interferon beta 1-a 44mcg Injection, 12000000 IU in 0.5ml, in

Specification Tenofovir Disoproxil Fumarate Tablets 300mg

Specification Dexamethasone Intravitreal Implant 0.7mg

Specification Ruxolitinib tablet 15mg

Specification Ruxolitinib tablet 5mg

Specification Ruxolitinib tablet 20mg

Specification Ruxolitinib tablet 15mg

Specification Ruxolitinib tablet 5mg

Specification Ruxolitinib tablet 20mg

Specification Dexamethasone Intravitreal Implant 0.7mg

Bid Evaluation Summary Sheet

Bids submitted without Bid Bonds, will not be considered.

7. Delivery of the items is to be made to free of charge.

8. Withdrawal from use of Item due to quality failure.

Now the Conditions of this Bond are:

This Bond shall be governed by the laws of ( )

I executed as a Deed this( )day of ( )20( )

You might also like